Osaka, Japan

Yasuyoshi Watanabe

This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Riken Corporation, Suntory Limited, Japan Science and Technology Agency. Active years: 1988-2025.

USPTO Granted Patents = 21 

% Patents Active = 66.7



Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 251(Granted Patents)


Location History:

  • Kyoto, JP (1988 - 1990)
  • Minoo-shi, Osaka, JP (1998)
  • Minoh, JP (1998)
  • Minoo, JP (2005)
  • Tokyo, JP (1996 - 2013)
  • Hyogo, JP (2012 - 2014)
  • Kobe, JP (2014)
  • Osaka, JP (1997 - 2020)
  • Wako, JP (2020)

Company Filing History:

goldMedal4 out of 888 
 
Riken Corporation
 patents
silverMedal3 out of 439 
 
Suntory Limited
 patents
bronzeMedal2 out of 1,328 
 
Japan Science and Technology Agency
 patents
4. 2 out of 373 
 
Japan Science and Technology Corporation
 patents
5. 2 out of 19 
 
Osaka Bioscience Institute
 patents
6. 2 out of 256 
 
Research Development Corporation of Japan
 patents
7. 1 out of 1 
 
Atsuo Hazato
 patent
8. 1 out of 191 
 
Ge Healthcare Limited
 patents
9. 1 out of 38 
 
Glytech, Inc.
 patents
10. 1 out of 99 
 
Meiji Co., Ltd.
 patents
11. 1 out of 16 
 
Nbc Meshtec Inc.
 patents
12. 1 out of 768 
 
Omron Healthcare Company Ltd.
 patents
13. 1 out of 57 
 
Osaka City University
 patents
14. 1 out of 1,040 
 
Osaka University
 patents
15. 1 out of 16,454 
 
Panasonic Corporation
 patents
16. 1 out of 2,903 
 
Seiko Instruments Inc
 patents
17. 1 out of 1,605 
 
Teijin Limited
 patents
18. 1 out of 57 
 
University Public Corporation Osaka
 patents
19. 2 out of 834,411 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Innovations by Yasuyoshi Watanabe: Pioneering Patents in Health and Technology

Introduction: Yasuyoshi Watanabe, an accomplished inventor based in Osaka, Japan, has made significant contributions to the fields of health and technology. With an impressive portfolio of 19 patents, Watanabe has carved a niche for himself through innovative ideas that aim to enhance human well-being and improve daily life.

Latest Patents: Among his latest inventions is the "Fermented Milk for Improving Autonomic Nervous Function." This fermented milk product focuses on the benefits of at least one lactic acid bacterial species, complemented by its metabolites. The patented strain is specifically selected from the genera known for their health benefits, notably subsp. OLL1073R-1 (FERM BP-10741).

Another notable patent is the "Fatigue Degree Determination Device and Fatigue Degree Determination Method." This invention introduces a device that captures two distinct biological heart rates: one while the user is awake and at rest, and the other during sleep. By analyzing these metrics, the device determines the user's fatigue level, utilizing historical data stored in a medium that correlates the variations in heart rates with fatigue assessments.

Career Highlights: Watanabe has been associated with leading companies such as Riken Corporation and Suntory Limited. His work in these institutions has played a pivotal role in advancing research and development in health-related technologies, enhancing both company profiles and public health.

Collaborations: Throughout his career, Watanabe has collaborated with esteemed professionals, including Masaaki Suzuki and Bengt Langstrom. Their combined efforts have fostered innovations that not only push the boundaries of scientific research but also aim to deliver real-world applications that benefit society.

Conclusion: Yasuyoshi Watanabe continues to be a driving force in the realm of innovations and patents, with a clear focus on health and technology. His contributions not only highlight his expertise as an inventor but also pave the way for further advancements in improving the quality of life through science. As he progresses in his career, one can anticipate more remarkable inventions that will continue to make a significant impact.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…